Please assess the completion status of the following clinical trial:

Trial Title: Influenza Vaccine in Premature Infants

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion criteria. Subjects must meet all relevant criteria to participate.~1. (a) Former premature (\< 30 weeks' gestation at birth), ELBW (\<1001 grams' birth weight) infant, 6 months, 0 days - 17 months, 31 days of age., OR (b) Former full term (37-42 weeks' gestation at birth), normal birth weight (\>2500 grams' birth weight) infant, 6 months, 0 days - 17 months, 31 days of age.~2. No prior influenza immunization.~3. Eligible for influenza immunization.~4. Parental permission.~5. Agreement of primary care provider.~6. Parents likely to be able to comply with study visits.~Exclusion criteria. Subjects may not participate if they meet any one of these criteria.~1. Known immunodeficiency.~2. Systemic corticosteroid administration at time of study enrollment.~3. Requiring supplemental oxygen.~4. Contraindication to influenza immunization (e.g. egg allergy).~5. Physician-diagnosed influenza illness in the current influenza season.~6. Any condition determined by investigator as likely to interfere with evaluation of the vaccine or be a significant potential health risk to the subject.

- Gender: ALL
- Minimum Age: 6 Months
- Maximum Age: 17 Months
- Healthy Volunteers: f

Study Arms:
- 1 (Type: None): Premature infants
- 2 (Type: None): Full term infants

Based on this trial design, predict the completion outcome and termination type (if applicable).